Association between saliva PSA and serum PSA in conditions with prostate adenocarcinoma

References

• Aksoy H, Akçay F, Umudum Z, Yildirim AK, Memisogullari R. (2002). Changes of PSA concentrations in serum and saliva of healthy women during the menstrual cycle. Ann Clin Lab Sci 32:31–36.
   PubMed Web of Science ®Google Scholar
• Ayatollahi H, Darabi Mahboub MR, Mohammadian N, Parizadeh MR, Kianoosh T, Khabbaz Khoob M, Kamalian F. (2007). Ratios of free to total prostate-specific antigen and total prostate specific antigen to protein concentrations in saliva and serum of healthy men. Urol j 4:238–241.
   PubMedGoogle Scholar
• Breul J, Pickl U, Hartung R. (1993). Prostate-specific antigenin urine and saliva. J Urol 149:302A.
   Google Scholar
• Brooks MN, Wang J, Li Y, Zhang R, Elashoff D, Wong DT. (2008). Salivary protein factors are elevated in breast cancer patients. Mol Med Report 1:375–378.
   PubMed Web of Science ®Google Scholar
• Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK, Sandberg AA. (1980). The LNCaP cell line–a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37:115–132.
   PubMedGoogle Scholar
• Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. (1983). LNCaP model of human prostatic carcinoma. Cancer Res 43:1809–1818.
   PubMed Web of Science ®Google Scholar
• Hu Y, Nakagawa Y, Purushotham KR, Humphreys-Beher MG. (1992). Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am j Physiol 263:E607–E614.
   PubMedGoogle Scholar
• Ishikawa T, Kashiwagi H, Iwakami Y, Hirai M, Kawamura T, Aiyoshi Y, Yashiro T, Ami Y, Uchida K, Miwa M. (1998). Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction. Jpn j Clin Oncol 28:723–728.
   PubMed Web of Science ®Google Scholar
• Ito K, Yamamoto T, Kubota Y, Suzuki K, Fukabori Y, Kurokawa K, Yamanaka H. (2000). Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer. Urology 56:278–282.
   PubMed Web of Science ®Google Scholar
• Mistry K, Cable G. (2003). Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. j Am Board Fam Pract 16:95–101.
   PubMedGoogle Scholar
• Mokhtari Azad T, Ehteda A, Yavari P, Hamkar R, Safar Pour Z, Essalat M, Nategh R. (2003). Comparative Detection of Measles Specific IgM Antibody in Serum and Saliva by an Antibody-Capture IgM Enzyme Immunoassay (EIA). Iran j Allergy Asthma Immunol 2:149–154.
   PubMedGoogle Scholar
• Montgomery BT, Young CY, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF, Tindall DJ. (1992). Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP. Prostate 21:63–73.
   PubMedGoogle Scholar
• Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. (1998). Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 35:275–368.
   PubMed Web of Science ®Google Scholar
• Saito S. (2007). Prostate-specific antigen cut-off point of 2.5 ng/mL and increasing the number of prostate biopsies results in the detection of curable prostate cancer even in Japanese population. Int j Urol 14:709–712.
   PubMed Web of Science ®Google Scholar
• Saruta J, Sato S, Tsukinoki K. (2010). The role of neurotrophins related to stress in saliva and salivary glands. Histol Histopathol 25:1317–1330.
   PubMed Web of Science ®Google Scholar
• Slev PR, La’ulu SL, Roberts WL. (2008). Intermethod differences in results for total PSA, free PSA, and percentage of free PSA. Am j Clin Pathol 129:952–958.
   PubMed Web of Science ®Google Scholar
• Streckfus CF, Mayorga-Wark O, Arreola D, Edwards C, Bigler L, Dubinsky WP. (2008). Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast. Cancer Invest 26:159–167.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. (2010). Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6:78–95.
   PubMed Web of Science ®Google Scholar
• Tazawa K, Kurihara Y, Kamoshida S, Tsukada K, Tsutsumi Y. (1999). Localization of prostate-specific antigen-like immunoreactivity in human salivary gland and salivary gland tumors. Pathol Int 49:500–505.
   PubMed Web of Science ®Google Scholar
• Wilson MJ, Sinha AA. (1997). Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells. Anat Rec 249:63–73.
   PubMedGoogle Scholar
• Yousef GM, Obiezu CV, Luo LY, Black MH, Diamandis EP. (1999). Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated. Cancer Res 59:4252–4256.
   PubMed Web of Science ®Google Scholar